Gilead Sciences Inc.’s antiviral drug has been cleared by U.S. regulators for emergency use in Covid-19 patients, President Donald Trump told reporters at the White House Friday, Bloomberg News reports.
Gilead Sciences Inc.’s antiviral drug has been cleared by U.S. regulators for emergency use in Covid-19 patients, President Donald Trump told reporters at the White House Friday, Bloomberg News reports.